Results-driven executive with extensive experience in radiopharma, oncology, biotech, and medical device sales. Builds high-performing sales teams that consistently exceed revenue targets while fostering trusted relationships with stakeholders, including C-Suite leaders. Implements innovative strategies to enhance performance and drive process improvements, while promoting employee development through effective coaching and collaboration.
Overview
26
26
years of professional experience
Work History
North Neurooncology Account Manager
Telix Pharmaceuticals
Fishers, Indiana
12.2024 - Current
Collaborated with distribution partners, medical team, and marketing to develop and execute pre-launch strategy
Educated neuro-oncology multi-disciplinary teams and nuclear medicine on glioma imaging deficits and importance of FET PET
Received multiple awards for Urgency , Collaboration and Teamwork
NORTH REGION SALES DIRECTOR
NOVOCURE
04.2013 - Current
Recruited to Novocure as a Territory Manager (1 of 4 initial sales employees) and was quickly promoted within 2 years as Sales Manager. Sets the overall sales and marketing strategic vision within 9 territories, across 8 states. Led a team of 9 territory managers in the sale of a novel disruptive device (Optune) designed to help treat Newly Diagnosed and Recurrent Glioblastoma Multiforme. Identifies target customer base and influences sales. Launched novel therapy in two indications. Develops and manages relationships with key medical professionals, hospital systems, C-Suite executives, and cross-functional teams.
Maintained a consistent upward trend in sales growth; accomplished 65% and 61% sales increases in 2015 and 2016 respectively. Sustained 2016 sales growth into 2017. Grew sales by 14% in 2018, 8% in 2019, 10% in 2020, 3% in 2021, and 10% in 2022.
Recruited, developed, and retained high-performing employees to build a cohesive sales team with a keen focus on the customer.
Expanded sales volume for key accounts from 25 in 2013 to 142 in 2022, significantly enhancing regional market presence.
Acted as a leadership member of the NSCLC Pre-Launch Committee and Glioblastoma Product Team to contribute valuable insights and expertise to guide strategic decisions and initiatives.
Trained Neurosurgeons, Radiation Oncologists, Neuro Oncologists, and Medical Oncologists in the use of the Optune device.
Implemented Prescription Process Improvement Pilot in collaboration with Intake Team to address COVID-19 challenges, resulting in streamlined prescription process adopted permanently.
Senior Oncology Sales Specialist
OSI BIOTECH/ASTELLAS ONCOLOGY
09.2006 - 03.2013
Joined OSI to drive territory sales and increase the visibility and brand awareness of Tarceva in NYC, Westchester and CT Territory. Designed and implemented strategic plans to facilitate and grow Tarceva use in NSCLC and Pancreatic Cancer. Established and maintained excellent relationships with key Academic Lung and GU Medical Oncologists, earning respect for extensive clinical acumen and fostering effective collaborations within the medical oncology community.
Established relationships with KOLs, participated in customer calls, and launched products at high-profile academic institutions.
Launched Xtandi in Metastatic HRPC Market with 160% Goal Attainment
Trained sales team on effective strategies and product knowledge from 2010 to 2012.
Recipient of: 2007 & 2009- President's Club Award;2008-Culture Award; 2011-Top Territory Award
Promoted Tarceva for the treatment of NSCLC and pancreatic cancer. Addressed reimbursement issues to facilitate patient access to the medication.
Product Team Member 2009-2010
Represented the sales team on the 2008 National Sales Meeting Committee, developing and facilitating sales training and customer access workshops.
Senior Oncology Sales Specialist
NOVARTIS ONCOLOGY
09.2004 - 09.2006
Promoted Zometa and Femara in Multiple Myeloma, Solid Tumor, and breast cancer treatment, making Zometa cash positive for the first time in years, ensuring net revenue positive status for each customer, and adding 20+ new customer accounts to drive revenue growth over 30% to more than $12M in 18 months.
Converted key accounts to Zometa by building relationships with stakeholders.
Completed a preceptorship at MD Anderson Cancer Center from April 11-15, 2005.
Presented and Facilitated Session on Osteonecrosis of the Jaw at Phase IV Training
Presented and facilitated a session on osteonecrosis of the jaw at Phase IV training, enhancing understanding among peers.
Senior Oncology Sales Specialist
AVENTIS ONCOLOGY
05.2000 - 09.2004
Clinical Sales Expert on Taxotere for Multiple Solid Tumor Indications
Coordinated educational initiatives for self and peers as area sales trainer, completed fifteen preceptorships to enhance medical expertise and facilitate Taxotere adoption among customers, planned and implemented district-wide educational programs and symposia with key thought leaders, executed tailored programs based on customer needs, and maintained expert knowledge of Taxotere and competitive data in FDA and compendia approved areas, specializing in breast and lung cancer management.
Executed launch of Taxotere for 1st and 2nd Line NSCLC in regional market
Developed key advocates and speakers by providing educational resources through partnerships, coaching, and consistent follow-up, and enhancing local and regional sales impact.
Incorporated an effective routing system to maximize customer focus while ensuring urgency, utilized strong data analysis and focused spreadsheets to identify trends and address potential issues.
Consistently exceeded sales goals. Top 5th percentile 2001, 2002 & 2003. 2000 Area of Excellence award Trip Winner, 2001 NOVA Award Recipient, Taxotere #1 Regional Award, Taxotere #9 National Award. 2001 year over year growth of 68% which was above national growth of 30%. 2003 Area Sales Associate of the Year. 2004 Area Growth Winner.